Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
Epithelial mesenchymal transition (EMT) is a crucial event likely involved in dissemination of epithelial cancer cells. This process enables them to acquire migratory/invasive properties, contributing to tumor and metastatic spread. To know if this event is an early one in breast cancer, we developed a clinical trial. The aim of this protocol was to detect circulating tumor cells endowed with mesenchymal and/or stemness characteristics, at the time of initial diagnosis. Breast cancer patients (n = 61), without visceral or bone metastasis were enrolled and analysis of these dedifferentiated circulating tumor cells (ddCTC) was realized.
AdnaGen method was used for enrichment cell selection. Then, ddCTC were characterized by RT-PCR study of the following genes: PI3Kα, Akt-2, Twist1 (EMT markers) and ALDH1, Bmi1 and CD44 (stemness indicators).
Among the studied primary breast cancer cohort, presence of ddCTC was detected in 39% of cases. This positivity is independant from tumor clinicopathological factors apart from the lymph node status.
Our data uniquely demonstrated that in vivo EMT occurs in the primary tumors and is associated with an enhanced ability of tumor cells to intravasate in the early phase of cancer disease. These results suggest that analysis of circulating tumor cells focused on cells showing mesenchymal or stemness characteristics might facilitate assessment of new drugs in clinical trials.
- Liu, MC, Shields, PG, Warren, RD, Cohen, P, Wilkinson, M, Ottaviano, YL, Rao, SB, Eng-Wong, J, Seillier-Moiseiwitsch, F, Noone, AM, Isaacs, C (2009) Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol 27: pp. 5153-5159 CrossRef
- Sieuwerts, AM, Kraan, J, Bolt, J, van der Spoel, P, Elstrodt, F, Schutte, M, Martens, JW, Gratama, JW, Sleijfer, S, Foekens, JA (2009) Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101: pp. 61-66 CrossRef
- Hüsemann, Y, Geigl, JB, Schubert, F, Musiani, P, Meyer, M, Burghart, E, Forni, G, Eils, R, Fehm, T, Riethmüller, G, Klein, CA (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13: pp. 58-68 CrossRef
- Wicha, MS (2006) Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 12: pp. 5606-5607 CrossRef
- Klein, CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9: pp. 302-312 CrossRef
- Chaffer, CL, Weinberg, RA (2011) Perspective on cancer cell metastasis. Science 331: pp. 1559-1564 CrossRef
- Thiery, JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: pp. 442-454 CrossRef
- Theodoropoulos, PA, Polioudaki, H, Agelaki, S, Kallergi, G, Saridaki, Z, Mavroudis, D, Georgoulias, V (2010) Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 288: pp. 99-106 CrossRef
- Tan, AR, Alexe, G, Reiss, M (2009) Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?. Breast Cancer Res Treat 115: pp. 453-495 CrossRef
- Cantrell, DA (2001) Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114: pp. 1439-1445
- Chau, NM, Ashcroft, M (2004) Akt2: a role in breast cancer metastasis. Breast Cancer Res 6: pp. 55-57 CrossRef
- Cheng, GZ, Chan, J, Wang, Q, Zhang, W, Sun, CD, Wang, LH (2007) Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: pp. 1979-1987 CrossRef
- Martin, A, Cano, A (2010) Tumorigenesis: Twist1 links EMT to self-renewal. Nat Cell Biol 12: pp. 924-925 CrossRef
- Ginestier, C, Hur, MH, Charafe-Jauffret, E, Monville, F, Dutcher, J, Brown, M, Jacquemier, J, Viens, P, Kleer, CG, Liu, S, Schott, A, Hayes, D, Birnbaum, D, Wicha, MS, Dontu, G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: pp. 555-567 CrossRef
- Al-Hajj, M, Wicha, MS, Benito-Hernandez, A, Morrison, SJ, Clarke, MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: pp. 3983-3988 CrossRef
- Aktas, B, Tewes, M, Fehm, T, Hauch, S, Kimmig, R, Kasimir-Bauer, S (2009) Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11: pp. R46 CrossRef
- Banys, M, Krawczyk, N, Becker, S, Jakubowska, J, Staebler, A, Wallwiener, D, Fehm, T, Rothmund, R (2011) The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer. Breast Cancer Res Treat.
- Woolf, B (1957) he log-likelihood ratio (the G test), Methods and tables for tests of heterogeneity in contingency tables. Ann Hum Genet 21: pp. 397-409 CrossRef
- Su, Y, Zheng, Y, Zheng, W, Gu, K, Chen, Z, Li, G, Cai, Q, Lu, W, Shu, XO (2011) Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer 11: pp. 292-303 CrossRef
- Reyal, F, Valet, F, de Cremoux, P, Mathiot, C, Decraene, C, Asselain, B, Brain, E, Delaloge, S, Giacchetti, S, Marty, M, Pierga, JY, Bidard, FC (2011) Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients. Ann Oncol 22: pp. 1458-1459 CrossRef
- Wang, Y, Zhou, BP (2011) Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer 30: pp. 603-611 CrossRef
- Vazquez-Martin, A, Oliveras-Ferraros, C, Cufí, S, Del Barco, S, Martin-Castillo, B, Menendez, JA (2010) Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle 9: pp. 3807-3814 CrossRef
- Yang, MH, Hsu, DS, Wang, HW, Wang, HJ, Lan, HY, Yang, WH, Huang, CH, Kao, SY, Tzeng, CH, Tai, SK, Chang, SY, Lee, OK, Wu, KJ (2010) Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12: pp. 982-992 CrossRef
- Kallergi, G, Papadaki, MA, Politaki, E, Mavroudis, D, Georgoulias, V, Agelaki, S (2011) Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res 13: pp. R59 CrossRef
- Mani, SA, Guo, W, Liao, MJ, Eaton, EN, Ayyanan, A, Zhou, AY, Brooks, M, Reinhard, F, Zhang, CC, Shipitsin, M, Campbell, LL, Polyak, K, Brisken, C, Yang, J, Weinberg, RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: pp. 704-715 CrossRef
- Morel, AP, Lièvre, M, Thomas, C, Hinkal, G, Ansieau, S, Puisieux, A (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: pp. e2888 CrossRef
- Braun, S, Pantel, K, Müller, P, Janni, W, Hepp, F, Kentenich, CR, Gastroph, S, Wischnik, A, Dimpfl, T, Kindermann, G, Riethmüller, G, Schlimok, G (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342: pp. 525-533 CrossRef
- Ménard, S, Bufalino, R, Rilke, F, Cascinelli, N, Veronesi, U, Colnaghi, MI (1994) Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer 70: pp. 709-712 CrossRef
- Wicha, MS, Hayes, DF (2011) Circulating tumor cells: not all detected cells are bad and not all bad cells are detected. J Clin Oncol 29: pp. 1508-1511 CrossRef
- Mego, M, De Giorgi, U, Dawood, S, Wang, X, Valero, V, Andreopoulou, E, Handy, B, Ueno, NT, Reuben, JM, Cristofanilli, M (2011) Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. Int J Cancer 129: pp. 417-423 CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/12/114/prepub
- Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Online Date
- March 2012
- Online ISSN
- BioMed Central
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Astralab clinical laboratory, 7-11 Avenue de Lattre de Tassigny, 87000, Limoges, France
- 2. Department of gynecology and surgery, Clinique du Colombier, 92 avenue Albert Thomas, 87100, Limoges, France